Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Dec;63(617):e852-8.
doi: 10.3399/bjgp13X675430.

Prevalence of treatment-resistant depression in primary care: cross-sectional data

Affiliations
Randomized Controlled Trial

Prevalence of treatment-resistant depression in primary care: cross-sectional data

Laura Thomas et al. Br J Gen Pract. 2013 Dec.

Abstract

Background: Antidepressants are often the first-line treatment for depression in primary care. However, not all patients respond to medication after an adequate dose and duration of treatment. Currently, there are no estimates of the prevalence of treatment-resistant depression (TRD) from UK primary care.

Aim: To estimate the prevalence of TRD in UK primary care. Design and setting Data were collected as part of a multicentre randomised controlled trial, from 73 general practices in UK primary care.

Method: Potential participants (aged 18-75 years who had received repeated prescriptions for antidepressants) were identified from general practice records. Those who agreed to be contacted were mailed a questionnaire that included questions on depressive symptoms (Beck Depression Inventory [BDI-II]), and adherence to antidepressants. Those who scored ≥14 on the BDI-II and had taken antidepressants for at least 6 weeks at an adequate dose were defined as treatment resistant.

Results: A total of 2439 patients completed the questionnaire (84% of those who agreed to be contacted), of whom 2129 had been prescribed an adequate dose of antidepressants for at least 6 weeks. Seventy-seven per cent (95% CI = 75% to 79%) had a BDI score of ≥14. Fifty-five per cent (95% CI = 53% to 58%) (n = 1177) met the study's definition of TRD, of whom 67% had taken their antidepressants for more than 12 months.

Conclusion: The high prevalence of TRD is an important challenge facing clinicians in UK primary care. A more proactive approach to managing this patient population is required to improve outcome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Flow chart of the CoBalT study recruitment process. BDI = Beck Depression Inventory.

References

    1. Singleton N, Bumpstead R, O’Brien M, Lee A, Meltzer H. Psychiatric morbidity among adults living in private households, 2000 (Reprinted from Psychiatric morbidity among adults living in private households, 2000: Summary report, 2001) Int Rev Psych. 2003;15(1–2):65–73. - PubMed
    1. Health and Social Care Information Centre (Prescribing and Primary Care Services) Prescriptions Dispensed in the Community: Statistics for England — 2001 to 2011. http://www.hscic.gov.uk/catalogue/PUB06941 (accessed 4 Nov 2013)
    1. National Services Scotland. Information Services Division. Prescribing & Medicines: Medicines for Mental Health — Financial Years 2002/03 to 2011/12. 2012. https://isdscotland.scot.nhs.uk/Health-Topics/Prescribing-and-Medicines/... (accessed 12 Nov 2013)
    1. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243–1252. - PubMed
    1. Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007;17(11):696–707. - PubMed

Publication types

Substances